HaemO2 is a biotechnology project based at the University's School of Life Sciences. The beauty of this research at Essex is the scientists have used genetic engineering to decrease the toxicity of haemoglobin in an artificial haemoglobin-based oxygen carrier (HBOC). They have also developed new methods to stabilise the protein outside of the red blood cell.
Currently, there are no issues on this topic.
